Clinical Pathology

Overview

The Laboratory and Genomic Medicine (LGM) Division provides subspecialty clinical pathology services and medical directorships to numerous hospital laboratories in the St. Louis metropolitan region.

The primary focus of the LGM faculty is to provide medical director services to the 1400-bed Barnes-Jewish Hospital (BJH) laboratories, and the laboratory in the outpatient Siteman Cancer Center with Comprehensive Cancer Center designation from the National Cancer Institute.  Approximately 6 million tests per year are performed in the BJH laboratories.  The BJH laboratories are accredited by the College of American Pathologists. A link to the BJH test catalog can be found here.

Subspecialties

The LGM Division includes five sections with numerous subspecialties:

Chemistry

Microbiology

Transfusion Medicine/HLA

Laboratory Hematology

Informatics

Specialty Laboratories

Card Title

Card description goes here

Learn More

Pathology Research Collaborative

Clinicians

The talented team behind groundbreaking discoveries in this subspecialty.

Oree M. Carroll and Lillian B. Ladenson Professor in Clinical Chemistry, Pathology & Immunology and Obstetrics & Gynecology

Associate Professor, Pathology & Immunology

Assistant Professor, Pathology & Immunology

Assistant Professor, Pathology & Immunology

Associate Professor, Pathology & Immunology

Professor, Pathology & Immunology

Associate Professor, Pathology & Immunology

Assistant Professor, Pathology and Immunology

Associate Professor, Pathology & Immunology

Associate Professor Pathology & Immunology

Assistant Professor, Pathology & Immunology

Associate Professor, Pathology & Immunology

Associate Professor, Pathology & Immunology

Assistant Professor, Pathology & Immunology

Highlights

In the early 1970s, trainees in laboratory medicine were challenged to integrate new computer technology and automation into the hospital laboratory environment. The results are highly automated, high-throughput medical laboratories operating today.

In the early 1980s, clinical pathologists utilized monoclonal antibody technology originally developed in the basic science laboratory to develop numerous new medical tests in endocrinology, cardiology and oncology.

In the 1990s, the recognition of new pathogens and human identification of the genes associated with disease processes led to the development of new molecular assays to effectively monitor and treat patients.

Check out our department timeline.